Go here to see the original:
Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
Read the rest here:
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
Read the original here:
Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
Levitee Labs Publishes First Revenue Figures for August 2021
Continued here:
Levitee Labs Publishes First Revenue Figures for August 2021
TFF Pharmaceuticals to Hold Third Quarter 2021 Financial and Business Results Conference Call on November 15, 2021
CRISPR Therapeutics to Host Virtual Event Highlighting CTX110™ Clinical Data
Read the original here:
CRISPR Therapeutics to Host Virtual Event Highlighting CTX110™ Clinical Data
Shockwave Medical to Report Third Quarter 2021 Financial Results on November 8, 2021
Adagene to Present at Upcoming Investor Conferences
See original here:
Adagene to Present at Upcoming Investor Conferences
Neuronetics Announces Commercial Agreement with Success TMS
Continued here:
Neuronetics Announces Commercial Agreement with Success TMS
Osmotica Pharmaceuticals plc to Present at Jefferies Virtual Healthcare Conference 2021
Read more from the original source:
Osmotica Pharmaceuticals plc to Present at Jefferies Virtual Healthcare Conference 2021
Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired…
Shockwave Medical to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021
Spero Therapeutics Provides Update on SPR720 Phase 2a Clinical Trial
Originally posted here:
Spero Therapeutics Provides Update on SPR720 Phase 2a Clinical Trial
Neoleukin Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days
Sorrento to Present Data Demonstrating STI-2020 Preserves Binding Against UK B.1.1.7 SARS-CoV-2 Mutated Spike Protein
Histogen Reports FDA Clinical Hold for Planned Phase 1/2 Trial of HST-003 for Knee Cartilage Regeneration
Genocea to Participate in the B. Riley Securities’ Virtual Oncology Investor Conference
Go here to see the original:
Genocea to Participate in the B. Riley Securities’ Virtual Oncology Investor Conference